Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-21-024479
Filing Date
2021-06-17
Accepted
2021-06-17 18:12:08
Documents
2
Period of Report
2021-06-17

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1539
2 EX-24 DOCUMENT attachment1.htm EX-24 3761
  Complete submission text file 0000899243-21-024479.txt   6609
Mailing Address 4350 EXECUTIVE DRIVE SUITE 325 SAN DIEGO CA 92121
Business Address
Kalali Amir H (Reporting) CIK: 0001403646 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40493 | Film No.: 211026231

Mailing Address 180 VARICK STREET NEW YORK NY 10014
Business Address 180 VARICK STREET NEW YORK NY 10014 (617) 699-5876
ATAI Life Sciences B.V. (Issuer) CIK: 0001840904 (see all company filings)

EIN.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations